Xiaoying Lan
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Effects of Esketamine on Postoperative Delirium and Postoperative Cognitive Function in Elderly Gastrointestinal Tumor Patients with Preoperative Anxiety.
Journal: Drug design, development and therapy
Published: March 18, 2025
Piperlongumine overcomes imatinib resistance by inducing proteasome inhibition in chronic myelogenous leukemia cells.
Journal: Journal of ethnopharmacology
Published: August 30, 2022
Pseudolaric acid B induces mitotic arrest and apoptosis in both imatinib-sensitive and -resistant chronic myeloid leukaemia cells.
Journal: European journal of pharmacology
Published: February 02, 2020
Proteasomal cysteine deubiquitinase inhibitor b-AP15 suppresses migration and induces apoptosis in diffuse large B cell lymphoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 22, 2019
Platinum pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via DUB inhibition-dependent caspase activation and Bcr-Abl downregulation.
Journal: Cell death & disease
Published: February 04, 2017
Bilirubin neurotoxicity is associated with proteasome inhibition.
Journal: Cell death & disease
Published: January 16, 2017
Cytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancer.
Journal: Cell death & disease
Published: January 12, 2017
Repurposing an antidandruff agent to treating cancer: zinc pyrithione inhibits tumor growth via targeting proteasome-associated deubiquitinases.
Journal: Oncotarget
Published: November 08, 2016
Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms.
Journal: Journal of hematology & oncology
Published: September 21, 2016
Platinum-containing compound platinum pyrithione is stronger and safer than cisplatin in cancer therapy.
Journal: Biochemical pharmacology
Published: April 29, 2016
Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivo.
Journal: Oncotarget
Published: August 10, 2015
Last Updated: 09/26/2026